| Oct 22 |
TELA Bio Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
|
| Oct 2 |
Orbimed Advisors LLC Reduces Stake in TELA Bio Inc
|
| Aug 25 |
Wall Street Breakfast: The Week Ahead
|
| Aug 14 |
TELA Bio Second Quarter 2024 Earnings: Misses Expectations
|
| Aug 13 |
TELA Bio, Inc. (TELA) Q2 2024 Earnings Call Transcript
|
| Aug 12 |
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 12 |
TELA Bio GAAP EPS of -$0.51 misses by $0.02, revenue of $16.1M misses by $2.36M
|
| Aug 12 |
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance
|
| Aug 8 |
Artivion (AORT) Surpasses Q2 Earnings and Revenue Estimates
|
| Jul 31 |
TELA Bio, Inc. (NASDAQ:TELA) has caught the attention of institutional investors who hold a sizeable 42% stake
|
